Match tier Institution-verified
Presence Current · Arkansas
Last published 2024
Sources Institutional record
Refreshed 2026-08-06

Megan W. Butler

Sourced from institutional research profiles (UAMS TRI or ARA).

Faculty Researcher

6 h-index 7 pubs 268 cited

  • Humans
  • Child
  • Child, Preschool
  • Infant
  • Female
  • Male
  • Phenotype
  • Adolescent
  • Lymphocyte Activation
  • Genetic Predisposition to Disease
  • Polymorphism, Single Nucleotide
  • Infant, Newborn
  • Non-alcoholic Fatty Liver Disease
  • B-Lymphocytes
  • Concanavalin A

Edit your profile

Biography and Research Information

OverviewAI-generated summary

Megan W. Butler's research focuses on adverse events associated with medical interventions, particularly gene therapy. Her work includes an examination of acute liver injury following delandistrogene moxeparvovec gene therapy, which required intravenous immunoglobulin treatment. Butler has published a total of seven scholarly works, which have garnered 268 citations, and holds an h-index of 6. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including Aravindhan Veerapandiyan and Eniya Beemarajan, on shared publications.

Metrics

  • h-index: 6
  • Publications: 7
  • Citations: 268

Selected Publications

  • Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin (2024)
    Pediatric Neurology 8 citations DOI OpenAlex
  • Patient perspective on exercise practices, preferences, and barriers in pediatric nonalcoholic fatty liver disease: A multicenter survey (2024)
    JPGN Reports 3 citations DOI OpenAlex

Collaboration Network

12 Collaborators 11 Institutions 1 Country

Top Collaborators

Similar Researchers

Based on overlapping research topics